Zacks.com on MSN
Tempus AI (TEM) Reports Q2 Loss, Beats Revenue Estimates
Tempus AI (TEM) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.13.
A significant technology, Transmission electron microscopy (TEM) has found its way into cell biology since 1940. When compared with light microscopes, TEM can achieve a very high resolution due to the ...
CANADA - 2025/04/23: In this photo illustration, the Tempus AI logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images) AstraZeneca ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results